Press Releases

Kansas City, KS - (June 19, 2017) - Cingulate Therapeutics, LLC, a privately held biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that Shane J. Schaffer, PharmD, Chairman and Chief Executive Officer...